Search results for "multiple sclerosis"

Is season of birth associated with multiple sclerosis?

2000

Objective - To compare the monthly distribution of multiple sclerosis (MS) patients' births with that of the Sicilian population. Background -Studies on the association between season of birth and risk of MS are scanty and controversial. Design and methods - Archives of the Institute of Neuropsychiatry of the Universities of Palermo and Catania were searched up to 1995 for definite MS patients (McDonald & Halliday criteria). The monthly distribution of MS patients' births (N=965) was compared with that of the Sicilian population (N = 5,608,307). Results -The distribution of births among MS patients compared with the general population was not different when tested by the X 2 statistic (P > …

Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?

2010

Objectives The aim of this report is to assess the safety of endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI). Although balloon angioplasty and stenting seem to be safe procedures, there are currently no data on the treatment of a large group of patients with this vascular pathology. Methods A total of 564 endovascular procedures (balloon angioplasty or, if this procedure failed, stenting) were performed during 344 interventions in 331 CCSVI patients with associated multiple sclerosis. Results Balloon angioplasty alone was performed in 192 cases (55.8%), whereas the stenting of at least one vein was required in the remaining 152 cases (44.2%). There were no majo…

Extracellular vesicles from CS fluid are possible biomarkers of multiple sclerosis disease status

2018

Multiple sclerosis (MS) is an autoimmune disease and several researches have been focused on identifying molecular biomarkers that could reflect its heterogeneous clinical course and determine the best treatment option for patients. Some studies identified extracellular vesicles (EVs) in both the cerebrospinal fluid (CSF) and also in blood samples of patients affected by inflammatory neurodegenerative diseases and multiple sclerosis. To monitor the disease onset and its progression we compared the amount of CSF-EVs and their surface markers in subjects affected by either MS or other neurological disorders correlating the EVs with clinical indicators of MS disease severity. EVs isolated by u…

Effect of extracellular vesicles from CSF of multiple sclerosis patients and healthy controls on astrocytes in culture

2017

INTRODUCTION Secretion of extracellular vesicles (EVs) and EV-mediated exchange of molecules among brain cells, under physiological conditions, has been described years ago. At the same time, ability of EVs to transfer proteins and nucleic acids to the surrounding cells, thus modifying their phenotypes, has been clearly demonstrated for tumor cells of different origins, including brain cancers. More recently, involvement of EVs in pathological processes affecting the Central Nervous System (CNS), and their capacity of transferring damaging cargoes have been also suggested. To explore these functions, we exposed primary cultures of astrocytes to EVs isolated from cerebral spinal fluid (CSF) …

Improvement of the expression of upper limb muscle strength and balance in a group of patients with multiple sclerosis, through a proprioceptive reha…

2022

In multiple sclerosis (MS) patients, symptoms such as: fatigue, lack of physical energy, spasticity, difficulty in performing movements, and motor coordination disorders, and with tremors, dizziness and postural instability are among the most common complications. Cattaneo et al. (2007) studied the effects of stability training on MS patients and described it as an effective intervention in reducing falls risk, improving stability, and strength. Therefore, the present study aimed to confirm early observations by the application of a proprioceptive rehabilitation program targeting balance and strength on MS patients. 13 subjects with MS, 5 male and 8 female, volunteered in the study. A MAP h…

In vitro model of blood-brain barrier and application on the study of the multiple sclerosis.

2008

In vitro models of blood-brain barrier and application in the study of the multiple sclerosis

2008

Akceptacja choroby jako mediator zależności pomiędzy niepełnosprawnością neurologiczną a jakością życia uwarunkowaną stanem zdrowia osób ze stwardnie…

2020

Stwardnienie rozsiane (sclerosis multiplex – SM) jest postępującą demielinizacyjną chorobą ośrodkowego układu nerwowego, która może prowadzić do trwałej niepełnosprawności. Z tego względu stanowi wyzwanie dla procesu adaptacji psychicznej i może prowadzić do obniżenia jakości życia. Celem pracy było określenie relacji pomiędzy niepełnosprawnością neurologiczną występującą w przebiegu SM, przystosowaniem do choroby wyrażonym przez stopień jej akceptacji oraz jakością życia uwarunkowaną stanem zdrowia. Materiał i metody: W badaniu wzięło udział 137 osób ze zdiagnozowanym SM. W badaniach wykorzystano Skalę niepełnosprawności neurologicznej szpitala Guy, Skalę akceptacji choroby oraz Skalę wpły…

Neuro-endocrine networks controlling immune system in health and disease

2014

The nervous and immune systems have long been considered as compartments that perform separate and different functions. However, recent clinical, epidemiological, and experimental data have suggested that the pathogenesis of several immune-mediated disorders, such as multiple sclerosis (MS), might involve factors, hormones, and neural mediators that link the immune and nervous system. These molecules are members of the same superfamily, which allow the mutual and bi-directional neural–immune interaction. More recently, the discovery of leptin, one of the most abundant adipocyte-derived hormones that control food intake and metabolism, has suggested that nutritional/metabolic status, acting …

Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab

2015

International audience; Natalizumab (NTZ), a monoclonal antibody recognizing the alpha4 integrin chain, has been approved for the treatment of active multiple sclerosis, but expose to the onset of a rare side effect, progressive multifocal leukoencephalopathy (PML). Estimating the individual risk of PML in NTZ-treated patients is a major challenge, and therapeutic strategies are mainly guided by the overall PML risk assessed by identified risk factors: JC virus (JCV) seropositivity, treatment duration (with peak incidence after 24 months), and the previous use of immunosuppressive therapies. Given that this stratification does not yet allow a precise individual prediction of PML, other pred…